By Devika Patel
Knoxville, Tenn., July 7 - Northwest Biotherapeutics, Inc. said it completed a $2.65 million private placement of stock.
The company sold restricted common shares at $0.75 per share.
Investors, which included SDS Capital and Linda F. Powers, also received 10% warrant coverage.
Northwest is a development-stage biotechnology company based in Bothell, Wash.
| Issuer: | Northwest Biotherapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $2.65 million
|
| Price: | $0.75
|
| Warrants: | 10% coverage
|
| Investors: | SDS Capital and Linda F. Powers
|
| Announcement date: | July 7
|
| Stock symbol: | OTCBB: NWBO
|
| Stock price: | $0.72 at close July 6
|
| Market capitalization: | $41.6 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
